Floatz logo

Capecitabine

Colonic Neoplasm

First Affiliated Hospital of Guangxi Medical UniversitySmall moleculePhase 3Active
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
81/ 100

Competitive context

13 Active assets in the Colonic Neoplasm cohort.

Asset / SponsorPhaseRating
Xaliplatin
First Affiliated Hospital of Guangxi Medical University
Phase 4BBB
Propofol
Hillel Yaffe Medical Center
Phase 4BB
Ertapenem
University of Ulm
Phase 4BB
Levofolinic Acid
Asan Medical Center
Phase 2BB
Sevoflurane
Uppsala University
Phase 4BB

View all 46 →

Same molecule, other indications

Capecitabine is also rated in:

rectal carcinomaActive
BBB
Indicative · Phase 4
73 / 100
View asset →
hormone receptor-positive breast cancerActive
BBB
Indicative · Phase 4
72 / 100
View asset →
colorectal neoplasmActive
BB
Indicative · Phase 4
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →